Chrysanthemum zawadskii ethanol extract inhibits the replication of alpha-coronavirus and beta-coronavirus

Chansoo Kim; Jang Hoon Kim; Siyun Lee; Chunghyeon Lee; Gwi Yeong Jang; Jihun Choi; Woochul Jung; Jayhyun Park; Junsoo Park

doi:10.1371/journal.pone.0326225

Abstract

Coronavirus can induce various diseases, from mild common cold to severe COVID-19. Coronavirus can be continuously prevalent, similar to the influenza virus, due to its frequent mutation of the RNA genome. Therefore, diverse methods are required to treat coronavirus-related diseases. Chrysanthemum zawadskii, found in Asian countries including Korea, has been traditionally used to treat various diseases, including cough, pneumonia, and common cold. However, the antiviral effects of Chrysanthemum zawadskii have not been reported yet. Here, we demonstrated that Chrysanthemum zawadskii ethanol extract (CZE) treatment interferes with the replication of alpha-coronavirus (HCoV-229E) and beta-coronavirus (HCoV-OC43). CZE treatment ameliorates beta-coronavirus-induced cytotoxicity and reduces plaque formation. CZE treatment inhibits the coronavirus protein and RNA expression, indicating CZE inhibits coronavirus replication. HPLC analysis showed that CZE contains many antiviral compounds, such as luteolin and isochlorogenic acid. These results indicate that CZE is a potent medicinal herb for treating coronavirus-related diseases.

Citation: Kim C, Kim JH, Lee S, Lee C, Jang GY, Choi J, et al. (2025) Chrysanthemum zawadskii ethanol extract inhibits the replication of alpha-coronavirus and beta-coronavirus. PLoS One 20(6): e0326225. https://doi.org/10.1371/journal.pone.0326225

Editor: Opeyemi Iwaloye, University of Alabama at Birmingham, UNITED STATES OF AMERICA

Received: February 11, 2025; Accepted: May 23, 2025; Published: June 18, 2025

Copyright: © 2025 Kim et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Data Availability: All relevant data are within the manuscript and its Supporting information files.

Funding: This study was supported by the Cooperative Research Program (RS-2022-RD010239) of the Rural Development Administration, Republic of Korea.

Competing interests: The authors have declared that no competing interests exist.

Introduction

Coronavirus can induce various diseases, from mild common cold to severe COVID-19 [1]. Common cold is caused by the infection of various viruses such as rhinovirus and adenovirus, and a significant portion of the common cold are caused by coronavirus [2,3]. Coronaviruses are a group of enveloped, positive-sense single stranded RNA viruses belonging to the family Coronaviridae [4]. Coronavirus can be persistently prevalent, similar to influenza virus, due to its frequent mutation of the RNA genome [5]. The occurrence of drug- or vaccine-resistant coronavirus can cause serious problems. For example, the omicron variant exhibits significant immune evasion, reducing the effectiveness of existing mRNA vaccines [6]. Additionally, certain variants were also resistant to monoclonal antibody treatments such as bamlanivimab [7]. Therefore, diverse methods are required to treat the coronavirus-related diseases.

Coronaviruses infect a wide range of hosts, including mammals and birds, and are classified into alpha, beta, gamma, and delta coronavirus. Only alpha and beta coronaviruses are known to infect humans [8]. Coronaviruses are important pathogens because they can spread from animals to humans and cause large outbreaks. Four human coronavirus strains (HCoV-OC43, HCoV-229E, HCoV-NL63, and HCoV-HKU1) are well known to induce the common cold, and they are responsible for 15–30% of the common cold in adults [9]. Beta coronavirus contains highly virulent coronavirus (SARS-CoV, MERS-CoV and SARS-CoV-2) [9]. Because HCoV-OC43 is a member of beta coronavirus, HCoV-OC43 is commonly used as an avirulent model for other virulent coronaviruses [10,11]. A recent study showed that the antibodies raised by seasonal human coronavirus, including HCoV-OC43, protect humans from critical COVID-19, indicating these two viruses share conserved antigenicity [12].

Chrysanthemum zawadskii (C. zawadskii) belongs to the family Asteraceae [13]. C. zawadskii is a perennial herb found in Asian countries including Korea (known as ‘Gu-Jeol-Cho’ in Korean) [14]. C. zawadskii has been traditionally used to treat various diseases such as cough, pneumonia, and common cold [15–17]. Recent studies showed that C. zawadskii extract treatment has an anti-inflammatory effect, and the detailed mechanisms were provided [18–21]. C. zawadskii extract treatment was also reported to alleviate the bone- and muscle-related diseases such as osteoarthritis and muscle atrophy [22–30]. In addition, recent studies showed that C. zawadskii treatment is helpful to hair growth [15,31,32]. However, the antiviral effect of C. zawadskii treatment has not been reported yet.

A significant portion of common cold cases are associated with human coronavirus infection, and C. zawadskii was traditionally used to treat common cold, pneumonia, and cough [15]. Here, we report that C. zawadskii ethanol extract (CZE) treatment interferes with the replication of beta-coronavirus (HCoV-OC43) and alpha-coronavirus (HCoV-229E). We also demonstrated that CZE ameliorates beta-coronavirus-induced cytotoxicity.

Materials and methods

Material and sample preparation

The aerial parts of CZE were collected and dried in August 2021 at Chungcheongbuk province, Republic of Korea, and were identified by Dr. J.H. Kim in the Department of Herbal Crop Research (DHCR), National Institute of Horticultural and Herbal Science (NIHHS). A sample specimen (CZA2108) was deposited at the Herbarium of DHCR, NIHHS. This plant’s dried aerial parts (10 g) were extracted three times with ethanol (40 mL). The weight of the concentrated solution after filtration was 750 mg. The sample for HPLC analysis was prepared by dissolving 2 mg of extract in 1 mL of 70% ethanol and then filtering with a membrane filter (0.2 µm, Pall Co., Ann Arbor, Mi, USA).

HPLC analysis

The sample was analyzed using an Agilent 1200 HPLC system (Agilent Technologies, Santa Clara, CA, USA). The mobile phase consisted of 0.1% formic acid in ACN (A) in acetonitrile and 0.1% formic acid in water, using the following: 0 min (2% A), 0−5 min (2−2% A), 5−12 min (2−5% A), 12−17 min (5−8% A), 17−65 min (8−30% A), 65−68 min (30−30% A), 68−78 min (30−50% A), 78−100 min (50−100% A), and 100−110 min (100−100% A). The injection volume, flow rate, and detection wave length were set at 10 μL, 1.0 mL/min, and 340 nm, respectively. The column was YMC-triart (3 μm, 100 × 4.6 mm, YMC Co., Kyoto, Japan).

Infection of coronavirus

HCoV-OC43 virus was purchased from ATCC (Rockville, MD, USA) and rhabdomyosarcoma (RD) cells were obtained from Korean Cell Line Bank (Seoul, Korea). RD cells were maintained in DMEM media (Welgene, Seoul, Korea) supplemented with 10% FBS (Thermo Fisher Scientific, Waltham, MA, USA). RD cells were infected with human coronavirus (10⁶ PFU/ml), as described previously [10]. Briefly, cells were incubated with the indicated dilutions of media containing coronavirus (MOI of 0.01), and the infected cells were maintained in MEM media supplemented with 2% FBS. For plaque formation, RD cells were incubated in a 12-well plate and infected with the indicated concentration of media containing coronavirus. Later, the infected cells were covered with the overlay medium (0.3% agarose). The infected cells were incubated for an additional 4 days and stained with 0.1% crystal violet solutions. Cell viability was measured using MTT assay as described previously [33]. All experiments using RD cells and HCoV-OC43 virus were conducted in accordance with approved biosafety protocols (BSL-2 level) (Supporting information #1-#4).

Western blot and immunofluorescent imaging

Western blot with anti-HCoV-OC43 antibody was used to evaluate the expression level of coronavirus proteins. Cells and conditioned media were separately collected and prepared with cell lysis buffer (50 mM NaCl, 50 mM HEPES (pH 7.5), and 1% NP40) containing a protease inhibitor. Prepared lysates were separated with SDS-PAGE and blotted into PVDF membrane filters (Bio-Rad, Hercules, CA, USA). Coronavirus proteins were detected with an anti-HCoV-OC43 antibody (Sigma-Aldrich, Saint Louis, MO, USA), and the membrane was blocked with 3% bovine serum albumin in TBS containing 0.1% Tween 20. Confocal analysis of the fluorescence was performed using a Zeiss LSM 800 confocal microscope (Carl Zeiss, Oberkochen, Germany) at the Neuroscience Translational Research Solution Center (Busan, South Korea).

Quantitative RT-PCR

Quantitative RT-PCR was used to measure the level of coronavirus RNA in the cells and conditioned media. Cells and media were separately collected, and total RNA was prepared using TRIZOL (Thermo Fisher Scientific) as manufacturer’s protocol. An equal amount of total RNA was used to synthesize cDNA using the M-MLV cDNA Synthesis kit (Enzynomics, Seoul, Korea). StepOnePlus Real-Time PCR system (Thermo Fisher Scientific) was used for qRT-PCR, and GAPDH gene was used as a control. Detailed primer sequences were described previously [10].

Scanning electron microscope (SEM)

For SEM imaging, RD cells were grown on sterilized 9 mm coverslips and infected with HCoV-OC43 for 3 days. Cells were fixed with 2.5% glutaraldehyde for 1 h and dehydrated in an ethanol series (20%, 40%, 60%, 80%, 90% and 100% Et-OH). After dehydration, the cells were air-dried using a vacuum desiccator for 1 h. Cells were coated with platinum, and images were captured using a Carl Zeiss SEM SUPRA 40 microscope (Carl Zeiss).

Statistical analysis

The results of Western blot, quantitative RT-PCR and MTT were evaluated by a 2-tailed Student’s t-test using Excel software (Microsoft, Redmond, WA, USA). A p-value of 0.05 was considered significant.

Results

Chrysanthemum zawadskii ethanol extract (CZE) decreased the expression of alpha coronavirus and beta coronavirus proteins

We attempted to find the plant extracts that inhibit coronavirus replication by examining the level of coronavirus. We found that Chrysanthemum zawadskii ethanol extract (CZE) decreases the expression of coronavirus protein. We evaluated the expression level of coronavirus proteins in the cells and conditioned media. Human beta-coronavirus infection (HCoV-OC43) results in the expression of coronavirus proteins, and CZE treatment decreased the expression level of coronavirus significantly (Fig 1A, top panel). We also quantitated the expression level of coronavirus proteins, and IC₅₀ in the conditioned media was lower than IC₅₀ in cell lysates (Fig 1A, bottom panel). These results indicate that CZE treatment decreased the expression of human beta-coronavirus (HCoV-OC43).

Download:

Fig 1. Chrysanthemum zawadskii ethanol extract (CZE) decreases the expression of coronavirus protein.

(A) RD cells were infected with human beta-coronavirus (HCoV-OC43) and treated with the indicated concentration of CZE. After 72 h of incubation, cell lysates and conditioned media were collected, and the amount of coronavirus protein was evaluated by Western blot (Top panel). Western bands were quantified and shown in the graph (bottom panel). (B) RD cells were infected with human alpha-coronavirus (HCoV-229E) and treated with the indicated concentration of CZE. Cell lysates and conditioned media were collected and subjected to Western blot (Top panel). The expression level of HCoV-229E proteins was quantified and shown in the graph (Bottom panel). Results are shown as mean ± SEM. Panel A includes five independent replicates (n = 5) for both lysate and media. Panel B includes four repeats for lysate and three replicates (n = 3) for media. Mock vs. CZE treatment: * p < 0.05, ** p < 0.01, *** p < 0.001.

https://doi.org/10.1371/journal.pone.0326225.g001

Because CZE treatment decreased beta-coronavirus (HCoV-OC43) replication, we also examined whether CZE can decrease alpha-coronavirus replication. We used HCoV-229E strain to test whether CZE can inhibit alpha-coronavirus replication. CZE treatment decreased the expression level of HCoV-229E in cells and the conditioned media (Fig 1B). Moreover, the IC₅₀ of CZE against HCoV-229E was lower than that against HCoV-OC43, suggesting greater sensitivity of HCoV-229E to CZE treatment (Fig 1B). These results indicate that CZE is effective against both strains.

Chrysanthemum zawadskii ethanol extract (CZE) ameliorates beta-coronavirus-induced cytotoxicity

Because CZE treatment inhibits the expression of coronavirus proteins in the cells and conditioned media, we examined whether CZE ameliorates the coronavirus-induced cytotoxicity. Human alpha coronavirus (HCoV-229E) infection does not show the cytopathic effect, and we used human beta coronavirus (HCoV-OC43) to examine the antiviral effect of CZE [10]. We performed the cell viability assay to determine the adequate concentration to examine the antiviral effects in vitro. We found that CZE showed minimal effects up to 60 µM. However, the CZE treatment at 80 µM showed a significant decrease in cell viability (Fig 2A). Infection with beta-coronavirus (HCoV-OC43) decreases cell viability significantly, and we examined whether CZE treatment ameliorates coronavirus-induced cytotoxicity. RD cells were infected with coronavirus, treated with CZE together, and the cell viability was examined. Human beta-coronavirus (HCoV-OC43) infection results in a decrease in cell viability by up to 60%, and CZE treatment increases the viable cells in a dose-dependent manner (Fig 2B). Microscopic images showed that the number of viable cells was increased by CZE treatment (Fig 2C). These results indicate that CZE interferes with beta-coronavirus-induced cytotoxicity.

Download:

Fig 2. Chrysanthemum zawadskii ethanol extract (CZE) inhibits coronavirus induced cytotoxicity.

(A) Cell viability was evaluated upon CZE treatment. RD cells were incubated with the indicated concentration of CZE for 24 h, and cell viability was measured using an MTT assay. (B) CZE treatment ameliorates coronavirus induced cell death. RD cells were infected with mock or coronavirus (HCoV-OC43) and treated with CZE for 72 h. (C) Microscopic images of coronavirus-infected cells with CZE treatment. (D) CZE treatment reduced coronavirus-mediated plaque formation. (E) The numbers of plaques were counted and shown in the graph. Panel A and B were performed with four independent replicates (n = 4), and results are shown as mean ± SEM. Panel E includes five independent experiments (n = 5). Mock vs. CZE treatment: * p < 0.05, ** p < 0.01, *** p < 0.001.

https://doi.org/10.1371/journal.pone.0326225.g002

We examined the antiviral effect of CZE treatment by examining plaque formation. When RD cells were infected with human beta-coronavirus (HCoV-OC43), we observed an increase in plaque number, which was dependent on the virus titer (Fig 2D). The treatment of CZE decreased the number of coronavirus-induced plaques in a dose-dependent manner (Fig 2D, E). These results indicate that CZE treatment ameliorates coronavirus-induced cytotoxicity.

CZE treatment decreased the replication of coronavirus

Coronavirus contains RNA genomes, and we evaluated the level of coronavirus RNA upon CZE treatment. We evaluated the coronavirus RNA level using quantitative RT-PCR and used the region of nucleoprotein (N), membrane protein (M), and RNA-dependent RNA polymerase. CZE treatment decreased the RNA level of human coronavirus (HCoV-OC43) in a dose-dependent manner in cells and conditioned media (Fig 3A). We also determined IC₅₀ and IC₅₀ in the conditioned media are lower than IC₅₀ in the cells (Fig 3B). The coronavirus RNA in the conditioned media is mainly derived from the released virus particle, and these results indicate that CZE treatment inhibits coronavirus replication.

Download:

Fig 3. CZE treatment inhibits human coronavirus replication.

(A) RD cells were infected with coronavirus (HCoV-OC43) and treated with CZE for 72 h. Total RNA was isolated from the cells and conditioned media, and the level of each RNA was evaluated using quantitative RT-PCR. (B) The IC₅₀ of CZE was determined and shown in the graph. Panel A includes five independent replicates (n = 5) for both cell lysates and conditioned media, and results are shown as mean ± SEM. Mock vs. CZE treatment: * p < 0.05, ** p < 0.01, *** p < 0.001.

https://doi.org/10.1371/journal.pone.0326225.g003

CZE treatment decreases the number of infected cells and virus particle production

Because CZE treatment decreased coronavirus proteins and RNA, we examined the number of infected cells by CZE treatment. RD cells were infected with beta coronavirus (HCoV-OC43) and immune-stained with anti-OC43 antibody. When the cells were treated with CZE, we observed that the number of infected cells decreased (Fig 4A). These results indicate that CZE treatment decreased the infected cells.

Download:

Fig 4. CZE treatment inhibits the coronavirus production.

(A) CZE treatment reduces the number of coronavirus-infected cells. RD cells were infected with the coronavirus (HCoV-OC43) and treated with CZE. The infected cells were fixed and immunostained with anti-HCoV-OC43 antibody. (B) CZE treatment inhibits the coronavirus production. Cells were analyzed by a scanning electron microscope (SEM). Scale Bars 1 μm.

https://doi.org/10.1371/journal.pone.0326225.g004

Next, we examined the coronavirus infection on the cell surface. RD cells were infected with HCoV-OC43, and we used a scanning electron microscope (SEM) to analyze the infected cell surface. HCoV-OC43 infected cells have surface projections and virus particles on the infected cell surface as described previously [34]. CZE treatment decreased coronavirus-induced virus particle production and surface projections in a dose-dependent manner (Fig 4B). These results indicate that CZE treatment decreased the coronavirus replication and infectivity.

HPLC analysis of CZE

We showed that the CZE extract interfered with human coronavirus replication, and we attempted to examine whether CZE contains the antiviral single compounds. HPLC analysis was used to find an active single compound in CZE and the respective signals of CZE, and a mixture of standard compounds were analyzed by HPLC [35]. They were detected at 340 nm for 110 min and each peak of CZE was identified by comparing those with the retention times of the standard compounds. Twelve compounds were detected in the CZE (2: chlorogenic acid, 21.2 min; 5: vicenin, 32.5 min; 6: isochaftoside, 35.0 min; 7: luteolin-7-O-glucoside, 38.2 min; 8: isochlorogenic acid B, 40.2 min; 9: isochlorogenic acid A, 41.6 min; 10: apigenin-7-O-glucoside, 43.1 min; 11: isochlorogenic acid, 44.7 min; 13: luteolin, 53.6 min; 14: apigenin, 61.2 min; 15: diosmetin, 63.9 min; 16: acacetin, 76.7 min) (Fig 5).

Download:

Fig 5. Antiviral compounds of CZE were determined by HPLC analysis.

The single compounds of CZE were analyzed by HPLC and their numbers are indicated in the graph. (1, neochlorogenic acid; 2, chlorogenic acid; 3, 4-O-caffeoylquinic acid; 4, 1,3-di-O-caffeoylquinic acid; 5, vicenin; 6, isochaftoside; 7, luteolin-7-O-glucoside; 8, isochlorogenic acid B; 9, isochlorogenic acid A; 10, apigenin-7-O-glucoside; 11, isochlorogenic acid; 12, biosmetin-7-O-glucoside; 13, luteolin; 14, apigenin; 15, diosmetin; 16, acacetin).

https://doi.org/10.1371/journal.pone.0326225.g005

Discussion

In this report, we attempted to find an herbal plant that is effective in treating coronavirus-related diseases. Chrysanthemum zawadskii was traditionally used to treat cough, common cold, and pneumonia, and coronavirus infection causes similar diseases, including common cold and pneumonia. A recent study showed that 15–30% of common cold is related with coronavirus infection [2]. Therefore, the inhibition of coronavirus replication by C. zawadskii can be related to treating of common cold and pneumonia.

When we examined the effect of C. zawadskii on coronavirus replication, we examined the effect of CZE on cell viability. CZE treatment did not show the significant cytotoxicity up to 40 µg/mL (Fig 2A). However, CZE can significantly inhibit the coronavirus protein and RNA expression at 5 µg/mL (Fig 1). Therefore, CZE can be treated without significant cytotoxicity, when the concentration of CZE is used below 40 µg/mL.

When we analyzed CZE using HPLC, we found many phenolic compounds in CZE. We found that CZE contains luteolin, apigenin, chlorogenic acid, and isochlorogenic acid. They are reported to have the potential to inhibit the replication SARS-CoV-2 in silico. Chlorogenic acid and isochlorogenic acid were reported to be a potent inhibitor of coronavirus replication [36–38]. In silico screening study showed that luteolin and apigenin are potent protease inhibitors of coronavirus [39,40]. These results indicate that CZE contains many potent antiviral compounds.

Here, we demonstrated that C. zawadskii extract (CZE) inhibits the replication of human alpha coronavirus (HCoV-229E) and human beta coronavirus (HCoV-OC43). Moreover, CZE ameliorates coronavirus-induced cytotoxicity. HPLC analysis showed that CZE contains many potent antiviral compounds. Because the ethnopharmacological evidence and the biological experiment data support CZE’s potential for treating coronavirus, CZE can be considered a candidate for this treatment. Further animal experiments should be followed to confirm its pharmacological effect on coronavirus-related diseases.

Supporting information

S1 Fig. Uncropped western blot images corresponding to Fig 1.

https://doi.org/10.1371/journal.pone.0326225.s001

(PDF)

S2 Fig. The raw MTT data for Fig 2A and Fig 2B.

https://doi.org/10.1371/journal.pone.0326225.s002

(CSV)

S3 Fig. Plaque formation data corresponding to Fig 2D.

https://doi.org/10.1371/journal.pone.0326225.s003

(CSV)

S4 Fig. The quantitative RT-PCR data for Fig 3.

https://doi.org/10.1371/journal.pone.0326225.s004

(CSV)

References

1. Paules CI, Marston HD, Fauci AS. Coronavirus infections—More than just the common cold. JAMA. 2020;323(8):707.
- View Article
- Google Scholar
2. Harrison CM, Doster JM, Landwehr EH, Kumar NP, White EJ, Beachboard DC, et al. Evaluating the virology and evolution of seasonal human coronaviruses associated with the common cold in the COVID-19 era. Microorganisms. 2023;11(2):445. pmid:36838410
- View Article
- PubMed/NCBI
- Google Scholar
3. Cui J, Li F, Shi Z-L. Origin and evolution of pathogenic coronaviruses. Nat Rev Microbiol. 2019;17(3):181–92. pmid:30531947
- View Article
- PubMed/NCBI
- Google Scholar
4. Zhou Z, Qiu Y, Ge X. The taxonomy, host range and pathogenicity of coronaviruses and other viruses in the Nidovirales order. Anim Dis. 2021;1(1):5. pmid:34778878
- View Article
- PubMed/NCBI
- Google Scholar
5. Focosi D, Quiroga R, McConnell S, Johnson MC, Casadevall A. Convergent evolution in SARS-CoV-2 spike creates a variant soup from which new COVID-19 waves emerge. Int J Mol Sci. 2023;24(3):2264. pmid:36768588
- View Article
- PubMed/NCBI
- Google Scholar
6. Cao Y, Wang J, Jian F, Xiao T, Song W, Yisimayi A, et al. Omicron escapes the majority of existing SARS-CoV-2 neutralizing antibodies. Nature. 2022;602(7898):657–63. pmid:35016194
- View Article
- PubMed/NCBI
- Google Scholar
7. Hoffmann M, Hofmann-Winkler H, Krüger N, Kempf A, Nehlmeier I, Graichen L, et al. SARS-CoV-2 variant B.1.617 is resistant to bamlanivimab and evades antibodies induced by infection and vaccination. Cell Rep. 2021;36(3):109415. pmid:34270919
- View Article
- PubMed/NCBI
- Google Scholar
8. Rabaan AA, Al-Ahmed SH, Haque S, Sah R, Tiwari R, Malik YS. SARS-CoV-2, SARS-CoV, and MERS-COV: a comparative overview. Infez Med. 2020;28(2):174–84.
- View Article
- Google Scholar
9. Liu DX, Liang JQ, Fung TS. Human Coronavirus-229E, -OC43, -NL63, and -HKU1 (Coronaviridae). Encyclopedia of Virology. Elsevier. 2021: 428–40. https://doi.org/10.1016/b978-0-12-809633-8.21501-x
10. Jang M, Park R, Park Y-I, Cha Y-E, Yamamoto A, Lee JI, et al. EGCG, a green tea polyphenol, inhibits human coronavirus replication in vitro. Biochem Biophysical Res Commun. 2021;547:23–8.
- View Article
- Google Scholar
11. Jang M, Park R, Yamamoto A, Park Y-I, Park Y, Lee S, et al. AMPK inhibitor, compound C, inhibits coronavirus replication in vitro. PLoS One. 2023;18(10):e0292309. pmid:37788269
- View Article
- PubMed/NCBI
- Google Scholar
12. Dugas M, Grote-Westrick T, Vollenberg R, Lorentzen E, Brix T, Schmidt H, et al. Less severe course of COVID-19 is associated with elevated levels of antibodies against seasonal human coronaviruses OC43 and HKU1 (HCoV OC43, HCoV HKU1). Int J Infect Dis. 2021;105:304–6. pmid:33636357
- View Article
- PubMed/NCBI
- Google Scholar
13. Baek J, Park S, Lee J, Min J, Park J, Lee GW. The complete chloroplast genome of Chrysanthemum zawadskii Herbich (Asteraceae) isolated in Korea. Mitochondrial DNA B Resour. 2021;6(7):1956–8. pmid:34179479
- View Article
- PubMed/NCBI
- Google Scholar
14. Jang AR, Lee HN, Hong JJ, Kim YM, Park JH. Ethanol extract of Chrysanthemum zawadskii inhibits the NLRP3 inflammasome by suppressing ASC oligomerization in macrophages. Exp Ther Med. 2023;25(3):128. pmid:36845948
- View Article
- PubMed/NCBI
- Google Scholar
15. Kim Y-D, Pi L-Q, Lee W-S. Effect of Chrysanthemum zawadskii extract on dermal papilla cell proliferation and hair growth. Ann Dermatol. 2020;32(5):395–401. pmid:33911774
- View Article
- PubMed/NCBI
- Google Scholar
16. Kim YY, Lee SY, D S Y. Biological activities of linarin from Chrysanthemum zawadskii var. latilobum. Yakhak Hoeji. 2001;45(6):604–10.
- View Article
- Google Scholar
17. Kwon HS, Ha TJ, Hwang SW, Jin YM, Nam SH, Park KH. Cytotoxic flavonoids from the whole plants of Chrysanthemum zawadskii Herbich var. latilobum Kitamura. J Life Sci. 2006;16(5):746–9.
- View Article
- Google Scholar
18. Cho BO, Shin JY, Kang HJ, Park JH, Hao S, Wang F, et al. Anti‑inflammatory effect of Chrysanthemum zawadskii, peppermint, Glycyrrhiza glabra herbal mixture in lipopolysaccharide‑stimulated RAW264.7 macrophages. Mol Med Rep. 2021;24(1). pmid:34036392
- View Article
- PubMed/NCBI
- Google Scholar
19. Hwang J, Jang B, Choi YW, Han I-O, Oh E-S. Synergistic anti-inflammatory effects of ethanol extracts from Chrysanthemum zawadskii flower and cudrania tricuspidata fruit occur via inhibition of the NF-κB signaling pathway. Evid Based Complement Alternat Med. 2023;2023:8198228. pmid:37779580
- View Article
- PubMed/NCBI
- Google Scholar
20. Wu T-Y, Khor TO, Saw CLL, Loh SC, Chen AI, Lim SS, et al. Anti-inflammatory/Anti-oxidative stress activities and differential regulation of Nrf2-mediated genes by non-polar fractions of tea Chrysanthemum zawadskii and licorice Glycyrrhiza uralensis. AAPS J. 2011;13(1):1–13. pmid:20967519
- View Article
- PubMed/NCBI
- Google Scholar
21. Kim B, Lee JH, Seo M-J, Eom SH, Kim W. Linarin down-regulates phagocytosis, pro-inflammatory cytokine production, and activation marker expression in RAW264.7 macrophages. Food Sci Biotechnol. 2016;25(5):1437–42. pmid:30263427
- View Article
- PubMed/NCBI
- Google Scholar
22. Lee T, Na C-B, Kim D, Han HJ, Yun J, Park SK, et al. Osteoarthritis improvement effect of Chrysanthemum zawadskii var. latilobum extract in relation to genotype. Int J Vitam Nutr Res. 2023;93(5):410–9. pmid:35023382
- View Article
- PubMed/NCBI
- Google Scholar
23. Suh KS, Rhee SY, Jung WW, Kim NJ, Jang YP, Kim HJ, et al. Chrysanthemum zawadskii extract protects osteoblastic cells from highly reducing sugar-induced oxidative damage. Int J Mol Med. 2013;32(1):241–50. pmid:23652775
- View Article
- PubMed/NCBI
- Google Scholar
24. Ha JK, Kim JS, Kim JY, Yun JB, Kim YY, Chung KS. Efficacy of GCWB106 (Chrysanthemum zawadskii var. latilobum extract) in osteoarthritis of the knee: A 12-week randomized, double-blind, placebo-controlled study. Medicine (Baltimore). 2021;100(26):e26542. pmid:34190191
- View Article
- PubMed/NCBI
- Google Scholar
25. Byun J-H, Choi C-W, Jang M-J, Lim SH, Han HJ, Choung S-Y. Anti-osteoarthritic mechanisms of Chrysanthemum zawadskii var. latilobum in MIA-induced osteoarthritic rats and interleukin-1β-induced SW1353 human chondrocytes. Medicina (Kaunas). 2020;56(12):685. pmid:33321982
- View Article
- PubMed/NCBI
- Google Scholar
26. Kim A-R, Kim HS, Kim DK, Lee JH, Yoo YH, Kim JY, et al. The extract of Chrysanthemum zawadskii var. latilobum Ameliorates Collagen-Induced Arthritis in Mice. Evid Based Complement Alternat Med. 2016;2016:3915013. pmid:27840652
- View Article
- PubMed/NCBI
- Google Scholar
27. Gu DR, Hwang J-K, Erkhembaatar M, Kwon K-B, Kim MS, Lee Y-R, et al. Inhibitory effect of Chrysanthemum zawadskii Herbich var. latilobum Kitamura Extract on RANKL-induced osteoclast differentiation. Evid Based Complement Alternat Med. 2013;2013:509482. pmid:24174976
- View Article
- PubMed/NCBI
- Google Scholar
28. Lee H, Kim YI, Nirmala FS, Jeong HY, Seo H-D, Ha TY, et al. Chrysanthemum zawadskil Herbich attenuates dexamethasone-induced muscle atrophy through the regulation of proteostasis and mitochondrial function. Biomed Pharmacother. 2021;136:111226. pmid:33485066
- View Article
- PubMed/NCBI
- Google Scholar
29. Yoo A, Jang YJ, Ahn J, Jung CH, Seo HD, Ha TY. Chrysanthemi Zawadskii var. Latilobum Attenuates obesity-induced skeletal muscle atrophy via regulation of PRMTs in skeletal muscle of mice. Int J Mol Sci. 2020;21(8):2811. pmid:32316567
- View Article
- PubMed/NCBI
- Google Scholar
30. Nirmala FS, Lee H, Kim Y-I, Hahm J-H, Seo H-D, Kim M, et al. Exercise-induced signaling activation by Chrysanthemum zawadskii and its active compound, linarin, ameliorates age-related sarcopenia through Sestrin 1 regulation. Phytomedicine. 2024;129:155695. pmid:38728922
- View Article
- PubMed/NCBI
- Google Scholar
31. Li Z, Li J, Gu L, Begum S, Wang Y, Sun B, et al. Chrysanthemum zawadskii extract induces hair growth by stimulating the proliferation and differentiation of hair matrix. Int J Mol Med. 2014;34(1):130–6. pmid:24807783
- View Article
- PubMed/NCBI
- Google Scholar
32. Begum S, Gu L-J, Lee M-R, Li Z, Li J-J, Hossain MJ, et al. In vivo hair growth-stimulating effect of medicinal plant extract on BALB/c nude mice. Pharm Biol. 2015;53(8):1098–103. pmid:25612775
- View Article
- PubMed/NCBI
- Google Scholar
33. Jang M, Park R, Kim H, Namkoong S, Jo D, Huh YH, et al. AMPK contributes to autophagosome maturation and lysosomal fusion. Sci Rep. 2018;8(1):12637. pmid:30140075
- View Article
- PubMed/NCBI
- Google Scholar
34. Park R, Jang M, Park Y-I, Park Y, Jung W, Park J, et al. Epigallocatechin Gallate (EGCG), a green tea polyphenol, reduces coronavirus replication in a mouse model. Viruses. 2021;13(12):2533. pmid:34960802
- View Article
- PubMed/NCBI
- Google Scholar
35. Lee S-E, Park S, Jang GY, Lee J, Moon M, Ji Y-J, et al. Extract of aster koraiensis nakai leaf ameliorates memory dysfunction via anti-inflammatory action. Int J Mol Sci. 2023;24(6):5765. pmid:36982837
- View Article
- PubMed/NCBI
- Google Scholar
36. Shi C, Liang W, Guo M, Yuan J, Zu S, Hu H. Chlorogenic acid inhibits porcine deltacoronavirus release by targeting apoptosis. Int Immunopharmacol. 2024;127:111359. pmid:38101217
- View Article
- PubMed/NCBI
- Google Scholar
37. Wang W-X, Zhang Y-R, Luo S-Y, Zhang Y-S, Zhang Y, Tang C. Chlorogenic acid, a natural product as potential inhibitor of COVID-19: virtual screening experiment based on network pharmacology and molecular docking. Nat Prod Res. 2022;36(10):2580–4. pmid:33769143
- View Article
- PubMed/NCBI
- Google Scholar
38. Zhang D, Hamdoun S, Chen R, Yang L, Ip CK, Qu Y, et al. Identification of natural compounds as SARS-CoV-2 entry inhibitors by molecular docking-based virtual screening with bio-layer interferometry. Pharmacol Res. 2021;172:105820. pmid:34403732
- View Article
- PubMed/NCBI
- Google Scholar
39. Wang W, Yang C, Xia J, Li N, Xiong W. Luteolin is a potential inhibitor of COVID-19: an in silico analysis. Medicine (Baltimore). 2023;102(38):e35029. pmid:37746970
- View Article
- PubMed/NCBI
- Google Scholar
40. Farhat A, Ben Hlima H, Khemakhem B, Ben Halima Y, Michaud P, Abdelkafi S, et al. Apigenin analogues as SARS-CoV-2 main protease inhibitors: In-silico screening approach. Bioengineered. 2022;13(2):3350–61. pmid:35048792
- View Article
- PubMed/NCBI
- Google Scholar

[ref1] 1. Paules CI, Marston HD, Fauci AS. Coronavirus infections—More than just the common cold. JAMA. 2020;323(8):707.
View Article
Google Scholar

[2] View Article

[3] Google Scholar

[ref2] 2. Harrison CM, Doster JM, Landwehr EH, Kumar NP, White EJ, Beachboard DC, et al. Evaluating the virology and evolution of seasonal human coronaviruses associated with the common cold in the COVID-19 era. Microorganisms. 2023;11(2):445. pmid:36838410
View Article
PubMed/NCBI
Google Scholar

[5] View Article

[6] PubMed/NCBI

[7] Google Scholar

[ref3] 3. Cui J, Li F, Shi Z-L. Origin and evolution of pathogenic coronaviruses. Nat Rev Microbiol. 2019;17(3):181–92. pmid:30531947
View Article
PubMed/NCBI
Google Scholar

[9] View Article

[10] PubMed/NCBI

[11] Google Scholar

[ref4] 4. Zhou Z, Qiu Y, Ge X. The taxonomy, host range and pathogenicity of coronaviruses and other viruses in the Nidovirales order. Anim Dis. 2021;1(1):5. pmid:34778878
View Article
PubMed/NCBI
Google Scholar

[13] View Article

[14] PubMed/NCBI

[15] Google Scholar

[ref5] 5. Focosi D, Quiroga R, McConnell S, Johnson MC, Casadevall A. Convergent evolution in SARS-CoV-2 spike creates a variant soup from which new COVID-19 waves emerge. Int J Mol Sci. 2023;24(3):2264. pmid:36768588
View Article
PubMed/NCBI
Google Scholar

[17] View Article

[18] PubMed/NCBI

[19] Google Scholar

[ref6] 6. Cao Y, Wang J, Jian F, Xiao T, Song W, Yisimayi A, et al. Omicron escapes the majority of existing SARS-CoV-2 neutralizing antibodies. Nature. 2022;602(7898):657–63. pmid:35016194
View Article
PubMed/NCBI
Google Scholar

[21] View Article

[22] PubMed/NCBI

[23] Google Scholar

[ref7] 7. Hoffmann M, Hofmann-Winkler H, Krüger N, Kempf A, Nehlmeier I, Graichen L, et al. SARS-CoV-2 variant B.1.617 is resistant to bamlanivimab and evades antibodies induced by infection and vaccination. Cell Rep. 2021;36(3):109415. pmid:34270919
View Article
PubMed/NCBI
Google Scholar

[25] View Article

[26] PubMed/NCBI

[27] Google Scholar

[ref8] 8. Rabaan AA, Al-Ahmed SH, Haque S, Sah R, Tiwari R, Malik YS. SARS-CoV-2, SARS-CoV, and MERS-COV: a comparative overview. Infez Med. 2020;28(2):174–84.
View Article
Google Scholar

[29] View Article

[30] Google Scholar

[ref9] 9. Liu DX, Liang JQ, Fung TS. Human Coronavirus-229E, -OC43, -NL63, and -HKU1 (Coronaviridae). Encyclopedia of Virology. Elsevier. 2021: 428–40. https://doi.org/10.1016/b978-0-12-809633-8.21501-x

[ref10] 10. Jang M, Park R, Park Y-I, Cha Y-E, Yamamoto A, Lee JI, et al. EGCG, a green tea polyphenol, inhibits human coronavirus replication in vitro. Biochem Biophysical Res Commun. 2021;547:23–8.
View Article
Google Scholar

[33] View Article

[34] Google Scholar

[ref11] 11. Jang M, Park R, Yamamoto A, Park Y-I, Park Y, Lee S, et al. AMPK inhibitor, compound C, inhibits coronavirus replication in vitro. PLoS One. 2023;18(10):e0292309. pmid:37788269
View Article
PubMed/NCBI
Google Scholar

[36] View Article

[37] PubMed/NCBI

[38] Google Scholar

[ref12] 12. Dugas M, Grote-Westrick T, Vollenberg R, Lorentzen E, Brix T, Schmidt H, et al. Less severe course of COVID-19 is associated with elevated levels of antibodies against seasonal human coronaviruses OC43 and HKU1 (HCoV OC43, HCoV HKU1). Int J Infect Dis. 2021;105:304–6. pmid:33636357
View Article
PubMed/NCBI
Google Scholar

[40] View Article

[41] PubMed/NCBI

[42] Google Scholar

[ref13] 13. Baek J, Park S, Lee J, Min J, Park J, Lee GW. The complete chloroplast genome of Chrysanthemum zawadskii Herbich (Asteraceae) isolated in Korea. Mitochondrial DNA B Resour. 2021;6(7):1956–8. pmid:34179479
View Article
PubMed/NCBI
Google Scholar

[44] View Article

[45] PubMed/NCBI

[46] Google Scholar

[ref14] 14. Jang AR, Lee HN, Hong JJ, Kim YM, Park JH. Ethanol extract of Chrysanthemum zawadskii inhibits the NLRP3 inflammasome by suppressing ASC oligomerization in macrophages. Exp Ther Med. 2023;25(3):128. pmid:36845948
View Article
PubMed/NCBI
Google Scholar

[48] View Article

[49] PubMed/NCBI

[50] Google Scholar

[ref15] 15. Kim Y-D, Pi L-Q, Lee W-S. Effect of Chrysanthemum zawadskii extract on dermal papilla cell proliferation and hair growth. Ann Dermatol. 2020;32(5):395–401. pmid:33911774
View Article
PubMed/NCBI
Google Scholar

[52] View Article

[53] PubMed/NCBI

[54] Google Scholar

[ref16] 16. Kim YY, Lee SY, D S Y. Biological activities of linarin from Chrysanthemum zawadskii var. latilobum. Yakhak Hoeji. 2001;45(6):604–10.
View Article
Google Scholar

[56] View Article

[57] Google Scholar

[ref17] 17. Kwon HS, Ha TJ, Hwang SW, Jin YM, Nam SH, Park KH. Cytotoxic flavonoids from the whole plants of Chrysanthemum zawadskii Herbich var. latilobum Kitamura. J Life Sci. 2006;16(5):746–9.
View Article
Google Scholar

[59] View Article

[60] Google Scholar

[ref18] 18. Cho BO, Shin JY, Kang HJ, Park JH, Hao S, Wang F, et al. Anti‑inflammatory effect of Chrysanthemum zawadskii, peppermint, Glycyrrhiza glabra herbal mixture in lipopolysaccharide‑stimulated RAW264.7 macrophages. Mol Med Rep. 2021;24(1). pmid:34036392
View Article
PubMed/NCBI
Google Scholar

[62] View Article

[63] PubMed/NCBI

[64] Google Scholar

[ref19] 19. Hwang J, Jang B, Choi YW, Han I-O, Oh E-S. Synergistic anti-inflammatory effects of ethanol extracts from Chrysanthemum zawadskii flower and cudrania tricuspidata fruit occur via inhibition of the NF-κB signaling pathway. Evid Based Complement Alternat Med. 2023;2023:8198228. pmid:37779580
View Article
PubMed/NCBI
Google Scholar

[66] View Article

[67] PubMed/NCBI

[68] Google Scholar

[ref20] 20. Wu T-Y, Khor TO, Saw CLL, Loh SC, Chen AI, Lim SS, et al. Anti-inflammatory/Anti-oxidative stress activities and differential regulation of Nrf2-mediated genes by non-polar fractions of tea Chrysanthemum zawadskii and licorice Glycyrrhiza uralensis. AAPS J. 2011;13(1):1–13. pmid:20967519
View Article
PubMed/NCBI
Google Scholar

[70] View Article

[71] PubMed/NCBI

[72] Google Scholar

[ref21] 21. Kim B, Lee JH, Seo M-J, Eom SH, Kim W. Linarin down-regulates phagocytosis, pro-inflammatory cytokine production, and activation marker expression in RAW264.7 macrophages. Food Sci Biotechnol. 2016;25(5):1437–42. pmid:30263427
View Article
PubMed/NCBI
Google Scholar

[74] View Article

[75] PubMed/NCBI

[76] Google Scholar

[ref22] 22. Lee T, Na C-B, Kim D, Han HJ, Yun J, Park SK, et al. Osteoarthritis improvement effect of Chrysanthemum zawadskii var. latilobum extract in relation to genotype. Int J Vitam Nutr Res. 2023;93(5):410–9. pmid:35023382
View Article
PubMed/NCBI
Google Scholar

[78] View Article

[79] PubMed/NCBI

[80] Google Scholar

[ref23] 23. Suh KS, Rhee SY, Jung WW, Kim NJ, Jang YP, Kim HJ, et al. Chrysanthemum zawadskii extract protects osteoblastic cells from highly reducing sugar-induced oxidative damage. Int J Mol Med. 2013;32(1):241–50. pmid:23652775
View Article
PubMed/NCBI
Google Scholar

[82] View Article

[83] PubMed/NCBI

[84] Google Scholar

[ref24] 24. Ha JK, Kim JS, Kim JY, Yun JB, Kim YY, Chung KS. Efficacy of GCWB106 (Chrysanthemum zawadskii var. latilobum extract) in osteoarthritis of the knee: A 12-week randomized, double-blind, placebo-controlled study. Medicine (Baltimore). 2021;100(26):e26542. pmid:34190191
View Article
PubMed/NCBI
Google Scholar

[86] View Article

[87] PubMed/NCBI

[88] Google Scholar

[ref25] 25. Byun J-H, Choi C-W, Jang M-J, Lim SH, Han HJ, Choung S-Y. Anti-osteoarthritic mechanisms of Chrysanthemum zawadskii var. latilobum in MIA-induced osteoarthritic rats and interleukin-1β-induced SW1353 human chondrocytes. Medicina (Kaunas). 2020;56(12):685. pmid:33321982
View Article
PubMed/NCBI
Google Scholar

[90] View Article

[91] PubMed/NCBI

[92] Google Scholar

[ref26] 26. Kim A-R, Kim HS, Kim DK, Lee JH, Yoo YH, Kim JY, et al. The extract of Chrysanthemum zawadskii var. latilobum Ameliorates Collagen-Induced Arthritis in Mice. Evid Based Complement Alternat Med. 2016;2016:3915013. pmid:27840652
View Article
PubMed/NCBI
Google Scholar

[94] View Article

[95] PubMed/NCBI

[96] Google Scholar

[ref27] 27. Gu DR, Hwang J-K, Erkhembaatar M, Kwon K-B, Kim MS, Lee Y-R, et al. Inhibitory effect of Chrysanthemum zawadskii Herbich var. latilobum Kitamura Extract on RANKL-induced osteoclast differentiation. Evid Based Complement Alternat Med. 2013;2013:509482. pmid:24174976
View Article
PubMed/NCBI
Google Scholar

[98] View Article

[99] PubMed/NCBI

[100] Google Scholar

[ref28] 28. Lee H, Kim YI, Nirmala FS, Jeong HY, Seo H-D, Ha TY, et al. Chrysanthemum zawadskil Herbich attenuates dexamethasone-induced muscle atrophy through the regulation of proteostasis and mitochondrial function. Biomed Pharmacother. 2021;136:111226. pmid:33485066
View Article
PubMed/NCBI
Google Scholar

[102] View Article

[103] PubMed/NCBI

[104] Google Scholar

[ref29] 29. Yoo A, Jang YJ, Ahn J, Jung CH, Seo HD, Ha TY. Chrysanthemi Zawadskii var. Latilobum Attenuates obesity-induced skeletal muscle atrophy via regulation of PRMTs in skeletal muscle of mice. Int J Mol Sci. 2020;21(8):2811. pmid:32316567
View Article
PubMed/NCBI
Google Scholar

[106] View Article

[107] PubMed/NCBI

[108] Google Scholar

[ref30] 30. Nirmala FS, Lee H, Kim Y-I, Hahm J-H, Seo H-D, Kim M, et al. Exercise-induced signaling activation by Chrysanthemum zawadskii and its active compound, linarin, ameliorates age-related sarcopenia through Sestrin 1 regulation. Phytomedicine. 2024;129:155695. pmid:38728922
View Article
PubMed/NCBI
Google Scholar

[110] View Article

[111] PubMed/NCBI

[112] Google Scholar

[ref31] 31. Li Z, Li J, Gu L, Begum S, Wang Y, Sun B, et al. Chrysanthemum zawadskii extract induces hair growth by stimulating the proliferation and differentiation of hair matrix. Int J Mol Med. 2014;34(1):130–6. pmid:24807783
View Article
PubMed/NCBI
Google Scholar

[114] View Article

[115] PubMed/NCBI

[116] Google Scholar

[ref32] 32. Begum S, Gu L-J, Lee M-R, Li Z, Li J-J, Hossain MJ, et al. In vivo hair growth-stimulating effect of medicinal plant extract on BALB/c nude mice. Pharm Biol. 2015;53(8):1098–103. pmid:25612775
View Article
PubMed/NCBI
Google Scholar

[118] View Article

[119] PubMed/NCBI

[120] Google Scholar

[ref33] 33. Jang M, Park R, Kim H, Namkoong S, Jo D, Huh YH, et al. AMPK contributes to autophagosome maturation and lysosomal fusion. Sci Rep. 2018;8(1):12637. pmid:30140075
View Article
PubMed/NCBI
Google Scholar

[122] View Article

[123] PubMed/NCBI

[124] Google Scholar

[ref34] 34. Park R, Jang M, Park Y-I, Park Y, Jung W, Park J, et al. Epigallocatechin Gallate (EGCG), a green tea polyphenol, reduces coronavirus replication in a mouse model. Viruses. 2021;13(12):2533. pmid:34960802
View Article
PubMed/NCBI
Google Scholar

[126] View Article

[127] PubMed/NCBI

[128] Google Scholar

[ref35] 35. Lee S-E, Park S, Jang GY, Lee J, Moon M, Ji Y-J, et al. Extract of aster koraiensis nakai leaf ameliorates memory dysfunction via anti-inflammatory action. Int J Mol Sci. 2023;24(6):5765. pmid:36982837
View Article
PubMed/NCBI
Google Scholar

[130] View Article

[131] PubMed/NCBI

[132] Google Scholar

[ref36] 36. Shi C, Liang W, Guo M, Yuan J, Zu S, Hu H. Chlorogenic acid inhibits porcine deltacoronavirus release by targeting apoptosis. Int Immunopharmacol. 2024;127:111359. pmid:38101217
View Article
PubMed/NCBI
Google Scholar

[134] View Article

[135] PubMed/NCBI

[136] Google Scholar

[ref37] 37. Wang W-X, Zhang Y-R, Luo S-Y, Zhang Y-S, Zhang Y, Tang C. Chlorogenic acid, a natural product as potential inhibitor of COVID-19: virtual screening experiment based on network pharmacology and molecular docking. Nat Prod Res. 2022;36(10):2580–4. pmid:33769143
View Article
PubMed/NCBI
Google Scholar

[138] View Article

[139] PubMed/NCBI

[140] Google Scholar

[ref38] 38. Zhang D, Hamdoun S, Chen R, Yang L, Ip CK, Qu Y, et al. Identification of natural compounds as SARS-CoV-2 entry inhibitors by molecular docking-based virtual screening with bio-layer interferometry. Pharmacol Res. 2021;172:105820. pmid:34403732
View Article
PubMed/NCBI
Google Scholar

[142] View Article

[143] PubMed/NCBI

[144] Google Scholar

[ref39] 39. Wang W, Yang C, Xia J, Li N, Xiong W. Luteolin is a potential inhibitor of COVID-19: an in silico analysis. Medicine (Baltimore). 2023;102(38):e35029. pmid:37746970
View Article
PubMed/NCBI
Google Scholar

[146] View Article

[147] PubMed/NCBI

[148] Google Scholar

[ref40] 40. Farhat A, Ben Hlima H, Khemakhem B, Ben Halima Y, Michaud P, Abdelkafi S, et al. Apigenin analogues as SARS-CoV-2 main protease inhibitors: In-silico screening approach. Bioengineered. 2022;13(2):3350–61. pmid:35048792
View Article
PubMed/NCBI
Google Scholar

[150] View Article

[151] PubMed/NCBI

[152] Google Scholar

Figures

Abstract

Introduction

Materials and methods

Material and sample preparation

HPLC analysis

Infection of coronavirus

Western blot and immunofluorescent imaging

Quantitative RT-PCR

Scanning electron microscope (SEM)

Statistical analysis

Results

Chrysanthemum zawadskii ethanol extract (CZE) decreased the expression of alpha coronavirus and beta coronavirus proteins

Chrysanthemum zawadskii ethanol extract (CZE) ameliorates beta-coronavirus-induced cytotoxicity

CZE treatment decreased the replication of coronavirus

CZE treatment decreases the number of infected cells and virus particle production

HPLC analysis of CZE

Discussion

Supporting information

S1 Fig. Uncropped western blot images corresponding to Fig 1.

S2 Fig. The raw MTT data for Fig 2A and Fig 2B.

S3 Fig. Plaque formation data corresponding to Fig 2D.

S4 Fig. The quantitative RT-PCR data for Fig 3.

References